Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark J. Gergen currently holds 96,372 shares of Poseida Therapeutics, Inc. (PSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark J. Gergen has been a net seller of PSTX stock. They have purchased $0 and sold $796.0K worth of shares.
Mark J. Gergen's most recent insider trade was on Dec 10, 2024, when they sold 30,000 shares at $0.00 per share.
Mark J. Gergen serves as Executive at Poseida Therapeutics, Inc. (PSTX). They have executed 70 insider transactions totaling $796.0K over their tenure at the company.
Mark J. Gergen holds the position of Executive at Poseida Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Mark J. Gergen has shown a selling trading pattern, with $0 in total purchases and $796.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark J. Gergen was on Aug 8, 2012, when they sold $2.0M worth of AMLN shares. This transaction involved 64,338.2 shares at $31.00 per share.
Mark J. Gergen currently owns 96,372 shares of Poseida Therapeutics, Inc. (PSTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark J. Gergen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark J. Gergen has 70 Form 4 filings on record as an insider at Poseida Therapeutics, Inc..
Set alerts for Mark J. Gergen and 40,000+ other insiders.